CF
MRVI icon

Corebridge Financial’s Maravai LifeSciences MRVI Stock Holding History

Corebridge Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-54,109
Closed -$120K – 1713
2025
Q1 		$120K Sell
54,109
-803
-1% -$3.17K ﹤0.01% 2353
2024
Q4 		$299K Sell
54,912
-4,145
-7% -$26.7K ﹤0.01% 1944
2024
Q3 		$491K Sell
59,057
-364
-0.6% -$3.15K ﹤0.01% 1742
2024
Q2 		$426K Buy
+59,421
New +$513K ﹤0.01% 1783

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Corebridge Financial's MRVI Position: Q2 2025 in Review

Corebridge Financial sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 54,109 shares — an estimated $120K sold.

Corebridge Financial first reported a position in MRVI in Q2 2024 and held it in 4 quarters. The position peaked at $491K in Q3 2024. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • Corebridge Financial reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 54,109 Maravai LifeSciences shares in Q2 2025, an estimated $120K.
  • Corebridge Financial first reported a position in Maravai LifeSciences in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Maravai LifeSciences position peaked at $491K in Q3 2024.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.